Guardian Pharmacy Services, Inc.
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.54% | 17.42% | 16.86% | 14.66% | 13.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.54% | 17.42% | 16.86% | 14.66% | 13.29% |
| Cost of Revenue | 19.55% | 17.44% | 17.45% | 15.32% | 14.47% |
| Gross Profit | 19.52% | 17.31% | 14.49% | 12.09% | 8.76% |
| SG&A Expenses | 113.27% | 108.71% | 67.70% | 20.60% | -9.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.97% | 30.82% | 25.88% | 16.10% | 10.39% |
| Operating Income | -177.68% | -186.93% | -192.10% | -5.93% | 84.71% |
| Income Before Tax | -266.50% | -283.62% | -283.93% | -54.52% | 5.71% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -289.60% | -295.70% | -284.39% | -54.52% | 5.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 16.63% | -17.63% | -26.16% | -13.79% | 7.08% |
| Net Income | -463.21% | -476.84% | -481.65% | -75.62% | 15.86% |
| EBIT | -177.68% | -186.93% | -192.10% | -5.93% | 84.71% |
| EBITDA | -137.84% | -143.90% | -131.96% | -2.74% | 61.03% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.09% | -1.13% | -1.25% | 2.65% | 0.72% |